Correlation Between Iteos Therapeutics and Achieve Life
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Achieve Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Achieve Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Achieve Life Sciences, you can compare the effects of market volatilities on Iteos Therapeutics and Achieve Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Achieve Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Achieve Life.
Diversification Opportunities for Iteos Therapeutics and Achieve Life
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iteos and Achieve is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Achieve Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achieve Life Sciences and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Achieve Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achieve Life Sciences has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Achieve Life go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Achieve Life
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 0.45 times more return on investment than Achieve Life. However, Iteos Therapeutics is 2.21 times less risky than Achieve Life. It trades about -0.11 of its potential returns per unit of risk. Achieve Life Sciences is currently generating about -0.12 per unit of risk. If you would invest 790.00 in Iteos Therapeutics on November 3, 2024 and sell it today you would lose (36.00) from holding Iteos Therapeutics or give up 4.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. Achieve Life Sciences
Performance |
| Timeline |
| Iteos Therapeutics |
| Achieve Life Sciences |
Iteos Therapeutics and Achieve Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Achieve Life
The main advantage of trading using opposite Iteos Therapeutics and Achieve Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Achieve Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achieve Life will offset losses from the drop in Achieve Life's long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| Achieve Life vs. Apellis Pharmaceuticals | Achieve Life vs. Iteos Therapeutics | Achieve Life vs. Tscan Therapeutics | Achieve Life vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |